We are live on
!
Find out more
SGAM
Smith Group Asset Management Portfolio holdings
AUM
$2.46B
Turnover
25.53%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.94%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.64B
AUM Growth
+$225M
(+9.3%)
Cap. Flow
-$43.3M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
21.11%
Holding
476
New
66
Increased
37
Reduced
127
Closed
88
Avg Time Held
0.4
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$41.4M |
| 2 |
Archer Daniels Midland
ADM
|
+$26.7M |
| 3 |
Openlane
OPLN
|
+$26.1M |
| 4 |
IDEX
IEX
|
+$24.3M |
| 5 |
Huntington Ingalls Industries
HII
|
+$24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetApp
NTAP
|
+$51.5M |
| 2 |
Costco
COST
|
+$37.9M |
| 3 |
Honeywell
HON
|
+$26.6M |
| 4 |
Cooper Companies
COO
|
+$26.1M |
| 5 |
The Gap Inc
GAP
|
+$23.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 16.61% |
| 2 | Technology | 16.16% |
| 3 | Healthcare | 15.4% |
| 4 | Industrials | 13.4% |
| 5 | Financials | 11.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
LCI
151
DELISTED
Lannett Company, Inc.
LCI
| $2.65M | 0.1% |
20,046
+19,552
| +3,958% | +$2.07M |
2013 Q2
2 quarters
|
|
152
Chemed
CHE
$6.7B
| $2.56M | 0.1% |
33,461
-195
| -0.6% | -$14.4K |
2013 Q2
2 quarters
|
|
153
Sturm, Ruger & Co
RGR
$693M
| $2.55M | 0.1% |
34,844
-131
| -0.4% | -$9.24K |
2013 Q2
2 quarters
|
|
154
US Physical Therapy
USPH
$1.28B
| $2.43M | 0.09% |
69,003
+34,302
| +99% | +$1.12M |
2013 Q2
2 quarters
|
|
|
REGI
155
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.43M | 0.09% |
211,691
-1,164
| -0.5% | -$14.3K |
2013 Q2
2 quarters
|
|
156
BioCryst Pharmaceuticals
BCRX
$1.99B
| $2.22M | 0.08% |
291,983
-1,613
| -0.5% | -$10.2K |
2013 Q2
2 quarters
|
|
157
DELISTED
Spirit Airlines, Inc.
SAVE
| $2.15M | 0.08% |
47,221
-256
| -0.5% | -$10.9K |
2013 Q2
2 quarters
|
|
158
Comscore
SCOR
$51.9M
| $2.08M | 0.08% |
3,639
-2,224
| -38% | -$1.22M |
2013 Q3
1 quarter
|
|
|
GTS
159
DELISTED
Triple-S Management Corporation
GTS
| $1.96M | 0.07% |
+106,116
| New | +$1.9M |
2013 Q4
0 quarters
|
|
160
Steris
STE
$21.7B
| $1.95M | 0.07% |
40,584
-236
| -0.6% | -$10.8K |
2013 Q2
2 quarters
|
|
|
NTRI
161
DELISTED
NutriSystem, Inc.
NTRI
| $1.94M | 0.07% |
+118,074
| New | +$2.07M |
2013 Q4
0 quarters
|
|
|
ECOL
162
DELISTED
US Ecology, Inc.
ECOL
| $1.93M | 0.07% |
51,940
-335
| -0.6% | -$11.6K |
2013 Q2
2 quarters
|
|
|
AXAS
163
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.78M | 0.07% |
27,265
+27,018
| +10,938% | +$1.75M |
2013 Q3
1 quarter
|
|
164
Magnera Corp
MAGN
$393M
| $1.73M | 0.07% |
4,823
-35
| -0.7% | -$12.4K |
2013 Q2
2 quarters
|
|
|
ICPT
165
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.67M | 0.06% |
24,455
-125
| -0.5% | -$7.22K |
2013 Q3
1 quarter
|
|
|
NUVA
166
DELISTED
NuVasive, Inc.
NUVA
| $1.5M | 0.06% |
+46,453
| New | +$1.4M |
2013 Q4
0 quarters
|
|
|
OREX
167
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $1.44M | 0.05% |
25,553
+6,751
| +36% | +$379K |
2013 Q2
2 quarters
|
|
168
Verastem
VSTM
$783M
| $1.42M | 0.05% |
+10,398
| New | +$1.37M |
2013 Q4
0 quarters
|
|
169
Cytokinetics
CYTK
$8.61B
| $1.38M | 0.05% |
212,669
+71,547
| +51% | +$470K |
2013 Q3
1 quarter
|
|
170
Vanda Pharmaceuticals
VNDA
$244M
| $1.37M | 0.05% |
+110,523
| New | +$1.11M |
2013 Q4
0 quarters
|
|
171
Achieve Life Sciences
ACHV
$658M
| $1.35M | 0.05% |
+74
| New | +$1.3M |
2013 Q4
0 quarters
|
|
|
AMAG
172
DELISTED
AMAG Pharmaceuticals
AMAG
| $1.33M | 0.05% |
54,850
-88
| -0.2% | -$2.07K |
2013 Q2
2 quarters
|
|
|
IPCC
173
DELISTED
Infinity Property & Casualty C
IPCC
| $1.3M | 0.05% |
18,072
-108
| -0.6% | -$7.38K |
2013 Q3
1 quarter
|
|
174
Quaker Houghton
KWR
$2.7B
| $1.3M | 0.05% |
16,813
-115
| -0.7% | -$8.84K |
2013 Q3
1 quarter
|
|
175
Artivion
AORT
$1.06B
| $1.12M | 0.04% |
101,136
-573
| -0.6% | -$5.39K |
2013 Q2
2 quarters
|
|
Similar funds
MAMU
PC
RG
DIA
Smith Group Asset Management's Q4 2013 Portfolio in Review
As of Q4 2013, Smith Group Asset Management held 476 positions worth $2.64B, up 9.3% from $2.41B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Smith Group Asset Management's Q4 2013 filing shows 66 new, 37 increased, 127 reduced and 88 closed positions. Its largest new stake was Archer Daniels Midland: 660,900 shares worth $28.7M. The largest sale was NetApp, an estimated $51.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- Smith Group Asset Management's largest Q4 2013 buy was Archer Daniels Midland: 660,900 shares worth $28.7M.
- Smith Group Asset Management added most to Apple in Q4 2013, an estimated $41.4M increase.
- Smith Group Asset Management's biggest Q4 2013 reduction was NetApp, cutting an estimated $51.5M.
- Smith Group Asset Management fully exited Costco in Q4 2013, selling an estimated $37.9M.
- Smith Group Asset Management's ten largest holdings make up 21% of its $2.64B portfolio in Q4 2013.
- Smith Group Asset Management opened 66 new positions and closed 88 in Q4 2013.
- Smith Group Asset Management's portfolio value rose 9.3% quarter-over-quarter to $2.64B.
Based on Smith Group Asset Management's 13F filing for Q4 2013, filed 29 Jan 2014.